Pharmacokinetic-pharmacodynamic integration of danofloxacin after intravenous, intramuscular and subcutaneous administration to rabbits

Journal of Veterinary Pharmacology and Therapeutics

Volumn 30, Issue 1, 2007, Pages 18-24

  Fernandez Varon E ^a   Marin, P ^a   Escudero, E ^a   Vancraeynest, D ^b   Carceles C M ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DANOFLOXACIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; SINGLE DRUG DOSE; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CROSS-OVER STUDIES; FEMALE; FLUOROQUINOLONES; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; MALE; MICROBIAL SENSITIVITY TESTS; RABBITS; STAPHYLOCOCCUS AUREUS;

ORYCTOLAGUS CUNICULUS; STAPHYLOCOCCUS AUREUS;

EID: 33846064223     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2007.00807.x     Document Type: Article

References (34)

1. Abd El-Aty, A.M., Goudah, A., Ismail, M. & Shimoda, M. (2005) Disposition kinetics of difloxacin in rabbit after intravenous and intramuscular injection of dicural. Veterinary Research Communications, 29, 297-304.
2. Aliabadi, F.S. & Lees, P. (2001) Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration. American Journal of Veterinary Research, 62, 1979-1989.
3. Atef, M., El-Gendi, A.Y., Aziza, Amer, M.M. & Abd El-Aty, A.M. (2001) Some pharmacokinetic data for danofloxacin in healthy goats. Veterinary Research Communications, 25, 367-377.
4. Broome, R.L., Brooks, D.L., Babish, J.G., Copeland, D.D. & Conzelman, G.M. (1991) Pharmacokinetic properties of enrofloxacin in rabbits. American Journal of Veterinary Research, 52, 1835-1841.
5. Brown, S.A. (1996) Fluoroquinolones in animal health. Journal of Veterinary Pharmacology and Therapeutics, 19, 1-14.
6. Cabanes, A., Arboix, M., García-Anton, J.M. & Reig, F. (1992) Pharmacokinetics of enrofloxacin after intravenous and intramuscular injection in rabbits. American Journal of Veterinary Research, 53, 2090-2093.
7. Cárceles, C.M., Serrano, J.M., Marín, P., Escudero, E. & Fernández-Varón, E. (2006) Pharmacokinetics of moxifloxacin in rabbits after intravenous, subcutaneous and a long-acting poloxamer P407 gel formulation. Journal of Veterinary Medicine A, 53, 300-304.
8. Cester, C., Schneider, M. & Toutain, P.L. (1996) Comparative kinetics of two orally administered fluoroquinolones in dog: enrofloxacin versus marbofloxacin. Revue de Medecine Veterinaire, 147, 703-716.
9. Drlica, K. & Zhao, X. (1997) DNA gyrase, topoisomerase i.v., and the 4-quinolones. Microbiology and Molecular Biology Reviews, 61, 377-392.
10. Drusano, G.L., Johnson, D.E., Rosen, M. & Standiford, H. (1993) Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrobial Agents and Chemotherapy, 37, 483-490.
11. Fernández-Varón, E., Bovaira, M.J., Espuny, A., Escudero, E., Vancraeynest, D. & Cárceles, C.M. (2005) Pharmacokinetic- pharmacodynamic integration of moxifloxacin in rabbits after intravenous, intramuscular and oral administration. Journal of Veterinary Pharmacology and Therapeutics, 27, 57-60.
12. Fernández-Varón, E., Villamayor, L., Escudero, E., Espuny, A. & Cárceles, C.M. (2006) Pharmacokinetics and milk penetration of moxifloxacin after intravenous and subcutaneous administration to lactating goats. The Veterinary Journal, 172, 302-307.
13. Gardner, S.Y., Davis, J.L., Jones, S.L., Lafevers, D.H., Hoskins, M.S., Mcarver, E.M. & Papich, M.G. (2004) Moxifloxacin pharmacokinetics in horses and disposition into phagocytes after oral dosing. Journal of Veterinary Pharmacology and Therapeutics, 27, 57-60.
14. Gibaldi, M. & Perrier, P. (1982) Pharmacokinetics, 2nd edn. Marcel-Dekker, New York.
15. Greko, C., Finn, M., Franklin, A. & Bengtsson, B. (2003). Pharmacokinetic/pharmacodynamic relationship of danofloxacin against Mannheimia haemolytica in a tissue-cage model in calves. Journal of Antimicrobial and Chemotherapy, 52, 253-257.
16. Hermans, K., De Herdt, P., Devriese, L.A., Hendrickx, W., Godard, C. & Haesebrouck, F. (1999) Colonisation of rabbits with Staphylococcus aureus in flocks with and without chronic staphylococcosis. Veterinary Microbiology, 67, 37-46.
17. Lode, H., Borner, K. & Koeppe, P. (1998) Pharmacodynamics of fluoroquinolones. Clinical Infectious Disease, 27, 33-39.
18. Marangos, M.N., Zhu, Z., Nicolau, D.P., Klepser, M.E. & Nightingale, C.H. (1997) Disposition of ofloxacin in female New Zealand white rabbits. Journal of Veterinary Pharmacology and Therapeutics, 20, 17-20.
19. Martínez, M., McDermott, P. & Walker, R. (2006) Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals. The Veterinary Journal, 172, 10-28.
20. McKellar, Q., Gibson, I., Monteiro, A. & Bregante, M. (1999) Pharmacokinetics of enrofloxacin and danofloxacin in plasma, inflammatory exudate, and bronchial secretions of calves following subcutaneous administration. Antimicrobial Agents and Chemotherapy, 43, 1988-1992.
21. McKellar, Q.A., Sanchez Bruni, S.F. & Jones, D.G. (2004) Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics, 27, 503-514.
22. NCCLS (2002) Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard. NCCLS document M31-A2. NCCLS, Wayne, PA (ISBN: 1-56238-461-9).
23. Powers, J. (1990) Statistical analysis of pharmacokinetic data. Journal of Veterinary Pharmacology and Therapeutics, 13, 113-120.
24. Shem-Tov, M., Rav-Hon, O., Ziv, G., Lavi, E., Glickman, A. & Saran, A. (1998) Pharmacokinetics and penetration of danofloxacin from the blood into the milk of cows. Journal of Veterinary Pharmacology and Therapeutics, 21, 209-213.
25. Shojaee Aliabadi, F. & Lees, P. (2003) Pharmacokinetic- pharmacodynamics integration of danofloxacin in the calf. Research in Veterinary Science, 74, 247-259.
26. Shojaee Aliabadi, F., Landoni, M.F. & Lees, P. (2003a) Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of danofloxacin in sheep biological fluids. Antimicrobial Agents and Chemotherapy, 47, 626-635.
27. Shojaee Aliabadi, F., Badrelin, H., Landoni, M.F. & Lees, P. (2003b) Pharmacokinetics and PK-PD modelling of danofloxacin in in camel serum and tissue cage fluids. The Veterinary Journal, 165, 104-118.
28. Shumaker, RC. (1986) PKCALC: a basic interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metabolism Reviews, 17, 331-348.
29. Siefert, H.M., Kohlsdorfer, C., Steinke, W. & Witt, A. (1999) Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: tissue distribution in male rats. Journal of Antimicrobial Chemotherapy, 43 (Suppl. B), 61-67.
30. Spreng, M., Deleforge, J., Thomas, E., Boisrame, B. & Drugeon, H. (1995) Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates. Journal of Veterinary Pharmacology and Therapeutics, 18, 284-289.
31. Turnidge, J. (1999) Pharmacokinetics and pharmacodynamics of fluoroquinolones. Drugs, 58, 29-36.
32. Wolfson, J.S. & Hooper, D.C. (1989) Fluoroquinolone antimicrobial agents. Clinical Microbiology Reviews, 2, 378-424.
33. Yamaoka, K., Nakagawa, T. & Uno, T. (1978) Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of Pharmacokinetics and Biopharmaceutics, 6, 165-175.
34. Yamaoka, K., Tamigawara, Y. & Uno, J. (1981) A pharmacokinetic analysis program (MULTI) for microcomputers. Journal of Pharmacobio- Dynamics, 4, 879-885.